1. The bladder microbiome and interstitial cystitis: is there a connection?
- Author
-
Melinda Abernethy and Angie Tsuei
- Subjects
Urinary tract function ,medicine.medical_specialty ,business.industry ,Microbiota ,Urinary system ,Urinary Bladder ,Cystitis, Interstitial ,Obstetrics and Gynecology ,Interstitial cystitis ,medicine.disease ,Gastroenterology ,Asymptomatic ,Painful Bladder Syndrome ,Internal medicine ,medicine ,Etiology ,Humans ,Female ,Microbiome ,medicine.symptom ,business ,Urine collection - Abstract
PURPOSE OF REVIEW Interstitial cystitis/painful bladder syndrome (PBS) is a debilitating condition, the etiology of which remains unclear and for which there are variable and often unsatisfactory treatment options. Within the last decade, evolving knowledge regarding the presence and role of the urinary microbiome has led to investigations regarding its impact on symptoms and severity of interstitial cystitis PBS. RECENT FINDINGS Since 2017, five studies have investigated differences between the microbiome of female patients with interstitial cystitis /PBS to asymptomatic controls. While varied in methodology, specifically with regard to urine collection processing and microbial detection, the majority of studies (4/5) found no association between urinary microbiota and interstitial cystitis /PBS. SUMMARY Research regarding the role of the urinary microbiome and lower urinary tract function and dysfunction, including interstitial cystitis /BPS, remains in preliminary stages. While data regarding the role of lactobacillus in lower urinary tract homeostasis is inconclusive, further research is warranted.
- Published
- 2021